Literature DB >> 23892591

Potential synergy between SNP and CpG-A or IL-1β in regulating transcriptional activity of IL-20 promoter.

Lanqi Wang1, Kejia Li1, Qiannan Xu1, Xiaoying Chen1, Feng Xue1, Ruofei Shi1, Jie Zheng2.   

Abstract

Psoriasis is a multifactorial cutaneous disorder that in many aspects is influenced by both genetic and environmental elements. IL-20, a member of IL-10 family, is found to be involved in the development of psoriasis. In our previous study, a single-nucleotide polymorphism (SNP) of IL-20-1723CG (rs1713239) was found to be associated with psoriasis progression, especially in those induced by upper respiratory tract infection. To further explore the underlying mechanism, we investigated the function of this specific variant and its cooperative effect with bacterial-like DNA or IL-1β on regulating IL-20 expression. We found that in HaCat cells, both IL-1β and CpG-A triggered a stronger IL-20 promoter activity with the risk-associated G allele in comparison with the nonrisk C allele of rs1713239. Furthermore, on stimulation with IL-1β or CpG-A, an increased level of IL-20 expression was also observed in psoriatic lesions of patients carrying the risk-associated G allele. This study demonstrates that rs1713239 and infection may have potential synergetic effect on modulating the transcriptional activity of IL-20.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23892591     DOI: 10.1038/jid.2013.314

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  29 in total

1.  IL-20 gene expression is induced by IL-1beta through mitogen-activated protein kinase and NF-kappaB-dependent mechanisms.

Authors:  Kristian Otkjaer; Knud Kragballe; Claus Johansen; Anne T Funding; Helle Just; Uffe B Jensen; Lotte G Sørensen; Peder L Nørby; Jes T Clausen; Lars Iversen
Journal:  J Invest Dermatol       Date:  2007-01-25       Impact factor: 8.551

Review 2.  Streptococcal tonsillitis and its association with psoriasis: a review.

Authors:  R J England; D R Strachan; L C Knight
Journal:  Clin Otolaryngol Allied Sci       Date:  1997-12

3.  Interleukin 20: discovery, receptor identification, and role in epidermal function.

Authors:  H Blumberg; D Conklin; W F Xu; A Grossmann; T Brender; S Carollo; M Eagan; D Foster; B A Haldeman; A Hammond; H Haugen; L Jelinek; J D Kelly; K Madden; M F Maurer; J Parrish-Novak; D Prunkard; S Sexson; C Sprecher; K Waggie; J West; T E Whitmore; L Yao; M K Kuechle; B A Dale; Y A Chandrasekher
Journal:  Cell       Date:  2001-01-12       Impact factor: 41.582

4.  Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types.

Authors:  L Dumoutier; C Leemans; D Lejeune; S V Kotenko; J C Renauld
Journal:  J Immunol       Date:  2001-10-01       Impact factor: 5.422

Review 5.  Therapeutic potential of Toll-like receptor 9 activation.

Authors:  Arthur M Krieg
Journal:  Nat Rev Drug Discov       Date:  2006-06       Impact factor: 84.694

6.  Interleukin-1 from epithelial cells fosters T cell-dependent skin inflammation.

Authors:  J Renne; V Schäfer; T Werfel; M Wittmann
Journal:  Br J Dermatol       Date:  2010-02-01       Impact factor: 9.302

Review 7.  Inflammasomes bridge signaling between pathogen identification and the immune response.

Authors:  A A Abdul-Sater; N Saïd-Sadier; D M Ojcius; O Yilmaz; K A Kelly
Journal:  Drugs Today (Barc)       Date:  2009-11       Impact factor: 2.245

8.  Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine a or calcipotriol.

Authors:  John Rømer; Erik Hasselager; Peder Lisby Nørby; Torben Steiniche; Jes Thorn Clausen; Knud Kragballe
Journal:  J Invest Dermatol       Date:  2003-12       Impact factor: 8.551

9.  Increased microorganisms DNA levels in peripheral blood monocytes from psoriatic patients using PCR with universal ribosomal RNA primers.

Authors:  Yukari Okubo; Noriko Oki; Hidemi Takeda; Misato Amaya; Sonoko Ito; Masako Osada; Masako Utsumi; Michiyuki Koga; Hisashi Kawashima
Journal:  J Dermatol       Date:  2002-09       Impact factor: 4.005

10.  Increased blood levels of IgG reactive with secreted Streptococcus pyogenes proteins in chronic plaque psoriasis.

Authors:  Rana G El-Rachkidy; Jonathan M Hales; Primrose P E Freestone; Helen S Young; Christopher E M Griffiths; Richard D R Camp
Journal:  J Invest Dermatol       Date:  2007-03-08       Impact factor: 8.551

View more
  1 in total

1.  First-In-Human, Phase 1, Randomized, Dose-Escalation Trial with Recombinant Anti-IL-20 Monoclonal Antibody in Patients with Psoriasis.

Authors:  Alice B Gottlieb; James G Krueger; Mia Sandberg Lundblad; Marie Göthberg; Brett E Skolnick
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.